The Myotonic Dystrophy Foundation supports scientific investigations to enhance the quality of life of people living with myotonic dystrophy (DM) and advance research focused on finding treatments and a cure for this disease. As a part of this effort, MDF offers a number of funding opportunities for DM researchers.
Current Funding Opportunities - 2021 Fellowship RFA
The Myotonic Dystrophy Foundation is pleased to announce that the 2021 Fellowship Request for Applications is now open. Myotonic has expanded the scientific research endeavors eligible for Ph.D. Trainee and Postdoctoral Fellowship awards to include research focused on improving treatment, care and support of the DM patient and his/her family, as well as molecular biology and basic and translational science. Trainees working in academia, research institutes or drug development companies are eligible.
Applications are due by September 18, 2020, with a start date for successful applicants of January 2021. Applicants are encouraged to contact MDF's Chief Executive Officer, Tanya Stevenson, with any questions about this RFA or the scientific content of their proposals. Technical issues should be directed to MDF's Research Coordinator Nadine Skinner.
Myotonic Dystrophy Foundation Grant Projects and Awards
Fund a Fellow
Since 2009 the Myotonic Dystrophy Foundation has committed over $3M in total research funding to 21 fellows from 17 different distinguished institutions in five countries. Many former fellows have remained in the DM research field after completing their fellowships and cited that they chose to continue in the field due to their interaction with the community, interest in the disease, and the research skills they gained. MDF is proud to support the development of new DM researchers, the advancement of DM academic research and discoveries, and to provide hope for the DM community by expanding our Fund-a-Fellow Program.
Grantwriting Training for Researchers
The Myotonic Dystrophy Foundation often hosts a grant writing training at the MDF Annual Conference. In 2016, the session was presented by Tom Cheever, PhD, Program Director at the National Institute of Arthritis and Musculoskeletal, and Skin Diseases (NIAMS). In 2017, the session was presented by MDF Chief Science Officer John Porter, PhD, former Program Director at the National Institute of Neuromuscular Disorders and Stroke (NINDS) at the U.S. National Institutes of Health (NIH). View the presentation slides from Dr. Cheever (presentation slides) and Porter (presentation slides) and access best-in-class grantwriting tips.
Subscribe to the Myotonic Dystrophy Foundation's research news publication, DM Research News, for updates about MDF and other funding opportunities. If you are not signed up for and receiving the DM Research News, complete this form with your name, degree, institution and current work or interest in DM care, research and/or drug development and we will enroll you in the monthly newsletter.
Email the Myotonic Dystrophy Foundation's Research Coordinator, Nadine Skinner, PhD, MPA.
For more information on MDF grantmaking policies, click here to read the MDF Request for Proposals Award Policy manual.